Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098669 · ClinicalTrials.gov registry record
Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 103
- Enrollment target
NCT01098669 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 103 participants.
The verdict
NCT01098669 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
RATIONALE: Collecting information about the impact of lymphedema on symptoms, functional status, and quality of life after treatment in patients with head and neck cancer may help doctors learn more about the disease and plan the best treatment. PURPOSE: This phase I trial is studying the effects of secondary lymphedema on symptoms, functional status, and quality of life after treatment in patients with head and neck cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01098669
The ClinicalTrials.gov registry entry for NCT01098669 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01098669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01098669 about?
NCT01098669 is a clinical study titled "Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer". RATIONALE: Collecting information about the impact of lymphedema on symptoms, functional status, and quality of life after treatment in patients with head and neck cancer may help doctors learn more about the disease and plan the best treatment. PURPOSE: This phase I trial is studying the effects o...
What is the current status of trial NCT01098669?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2009-12. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT01098669?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.